TICALICIBART
UNII N8BN99S4JQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Ticalicibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N8BN99S4JQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3033317-31-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N8BN99S4JQ

CAS Registry Number

3033317-31-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TICALICIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C223312

National Cancer Institute reference terminology for clinical and research data.

INN ID

13627

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ticalicibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TICALICIBART

Common Names & Synonyms

H-GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-441) (VH (HOMO SAPIENS IGHV3-30-5*03 (96.9%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT (8.8.7) (26-33.51-58.97-103)) (1-114) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, 12-G4V5 H P10(CH1 (115-212), HINGE 1-12 S10>P (222) (213-224), CH2 L92 (303) (225-334), CH3 (335-439), CHS (440-441)) (115-441)),(128-220')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-220') (V-KAPPA (HOMO SAPIENS IGKV4-1*01 (98.0%) -IGKJ1*01 (100%), CDR-IMGT (12.3.9) (27'-38'.56'-58'.95'-103')) (1'-113') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (159'), V101 (197')) (114'-220')); DIMER (220-220'':223-223'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G4 (222-PROLINE), ANTI-(HUMAN PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9) (HUMAN MONOCLONAL JK03 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JK03 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9)), HOMO SAPIENS MONOCLONAL ANTIBODY (TICALICIBART)

TICALICIBART [INN]

External Clinical & Regulatory Resources

Previous UNIIN8AL7T0ATT

Next UNIIN8BW9B8FEN